Recent trials reveal promising advancements in targeted therapies for chondrosarcomas and tenosynovial giant cell tumors.

Chondrosarcoma is a type of bone cancer that forms in the cells of cartilage. Symptoms can vary but may include swelling and pain in the area of the tumor. Surgery is usually the first treatment for ...

Improvement in Patient-Reported Outcomes With Intensity-Modulated Radiotherapy (RT) Compared With Standard RT: A Report From the NRG Oncology RTOG 1203 Study Twenty-one patients (escalation, n = 12; ...

Chondrosarcoma represents a heterogeneous group of primary malignant tumours arising from cartilaginous tissues. These tumours vary widely in clinical behaviour, ranging from slow-growing, locally ...

Chondrosarcoma is a malignant tumour characterised by the generation of a cartilaginous matrix by neoplastic cells. When occurring in the craniofacial region, particularly within the temporomandibular ...

Retrospective Analysis of BRCA-Altered Uterine Sarcoma Treated With Poly(ADP-ribose) Polymerase Inhibitors Chondrosarcomas are rare cancers of cartilage with limited systemic therapy options. To ...

Dublin, July 29, 2025 (GLOBE NEWSWIRE) -- The "Chondrosarcoma Market - A Global and Regional Analysis: Focus on Type, Treatment Type, and Region - Analysis and Forecast, 2025-2035" report has been ...

Mumbai: Dr Arsheed Hussain Hakeem, Senior Consultant – Surgical Oncology, Apollo Cancer Centre, Hyderabad speaking to Prabhat Prakash of ETHealthworld discussed the rarity of mesenchymal ...

The last time I spoke about Inhibrx Biosciences, Inc. (INBX) it was in a Seeking Alpha article entitled "Inhibrx: Positive Ozekibart Data For Bone Cancer Leads To Q2 2026 BLA Filing." With respect to ...

Please provide your email address to receive an email when new articles are posted on . The patient is a 57-year-old, right-handed, retired postal worker. He presented with a chief complaint of ...